Skip to main
ZYXI
ZYXI logo

Zynex Inc (ZYXI) Stock Forecast & Price Target

Zynex Inc (ZYXI) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 50%
Buy 33%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Zynex Inc, which specializes in the manufacturing and marketing of medical devices for pain management and rehabilitation, experienced a significant growth in orders, achieving a 16% year-over-year increase in FY2024. The company is focused on enhancing revenue per sales representative with a goal of reaching $1 million, while management has reported positive clinical study results for its laser-based system, positioning it as superior to current alternatives in the market. Additionally, the anticipated expense reductions and potential resolution of payer issues could lead to substantial savings and growth opportunities, further solidifying Zynex's favorable outlook in the medical device industry.

Bears say

Zynex Inc. has experienced significant financial challenges, with projected Q1 2025 sales indicating a decline of 37% year-over-year and 35% sequentially, reflecting ongoing struggles within its Electrotherapy and Pain Management Products segment. The company reported a total revenue of $46.0 million in Q4 2024, which marked a 3% year-over-year decline and fell short of expectations, with device sales down 9% year-over-year. Furthermore, Zynex’s guidance points to a sharp reduction in anticipated sales for 2025, now forecasted at $140 million compared to the previous estimate of $241 million, alongside a projected EPS loss of $0.50, emphasizing a lack of operational visibility and underlying business headwinds.

Zynex Inc (ZYXI) has been analyzed by 6 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 33% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Zynex Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Zynex Inc (ZYXI) Forecast

Analysts have given Zynex Inc (ZYXI) a Buy based on their latest research and market trends.

According to 6 analysts, Zynex Inc (ZYXI) has a Buy consensus rating as of Jul 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Zynex Inc (ZYXI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.